The president of the BioCubaFarma Biotech Conglomerate Eduardo Martinez announced the advancement in the development of a vaccine against Dengue Fever and the set up of a diagnostic system to detect the disease as the first symptoms appear.
The Mexican government announced the purchase of 9 million doses of the Cuban vaccine Abdala to immunize children between 5 and 11 years of age against Covid-19.
The main results achieved and the development prospects of the Cuban Biotechnological and Pharmaceutical Industries Group (BioCubaFarma), was the topic addressed by its president, Dr. Eduardo Martínez, who heads a representation of the creators of the Cuban anti-COVID-19 vaccines, in visit to Holguín.
The Cuban Ministry of Public Health (Minsap) reported today the death of the first patient, of Italian nationality, detected with monkeypox in the island.
The province of Holguín is facing a complex epidemiological situation due to the increase in positives for COVID-19 and dengue transmission in several municipalities.